Table 1.
Patients’ General Characteristics | N (%) |
---|---|
Sex | |
Male | 24 (80%) |
Female | 6 (20%) |
Median age at diagnosis (range) | 62 (40–81%) |
Primary tumor site | |
Ileum | 25 (83.3%) |
Stomach | 1 (3.3%) |
Duodenum | 2 (6.6%) |
Jejunum | 2 (6.6%) |
Metastatic disease at diagnosis (M1) | 14 (46.6%) |
Surgery before therapy with SSAs | 20 (66.6%) |
Median Ki67 value | 2 (1–10%) |
Grade | |
G1 | 20 (66.6%) |
G2 | 10 (33.3%) |
Carcinoid syndrome | 10 (33.3%) |
Pancreatic exocrine insufficiency | 5 (16.6%) |
Diabetes | 8 (26.6%) |
BMI | |
<18 (underweight) | 0 (0%) |
18–25 (normal weight) | 12 (40%) |
25–30 (overweight) | 13 (43.3%) |
>30 (obesity) | 5 (16.7%) |